# Enhancement of NK Cell Cytotoxicity Induced by Long-Term Living in Negatively Charged-Particle Dominant Indoor Air-Conditions

**Authors:** Yasumitsu Nishimura, Kazuaki Takahashi, Akinori Mase, Muneo Kotani, Kazuhisa Ami, Megumi Maeda, Takashi Shirahama, Suni Lee, Hidenori Matsuzaki, Naoko Kumagai-Takei, Kei Yoshitome, Takemi Otsuki

PMC · DOI: 10.1371/journal.pone.0132373 · 2015-07-14

## TL;DR

Living in indoor air conditions with negatively charged particles boosts natural killer (NK) cell activity, suggesting a potential health benefit.

## Contribution

The study demonstrates that long-term exposure to negatively charged particle-dominant indoor air activates NK cell cytotoxicity in humans.

## Key findings

- NK cell activity increased during ON trials and decreased during OFF trials.
- Epidermal growth factor (EGF) levels slightly increased during ON trials.
- Basic immune status was slightly stimulated during ON trials.

## Abstract

Investigation of house conditions that promote health revealed that negatively charged-particle dominant indoor air-conditions (NCPDIAC) induced immune stimulation. Negatively charged air-conditions were established using a fine charcoal powder on walls and ceilings and utilizing forced negatively charged particles (approximate diameter: 20 nm) dominant in indoor air-conditions created by applying an electric voltage (72 V) between the backside of the walls and the ground. We reported previously that these conditions induced a slight and significant increase of interleukin-2 during a 2.5-h stay and an increase of NK cell cytotoxicity when examining human subjects after a two-week night stay under these conditions. In the present study, seven healthy volunteers had a device installed to create NCPDIAC in the living or sleeping rooms of their own homes. Every three months the volunteers then turned the NCPDIAC device on or off. A total of 16 ON and 13 OFF trials were conducted and their biological effects were analyzed. NK activity increased during ON trials and decreased during OFF trials, although no other adverse effects were found. In addition, there were slight increases of epidermal growth factor (EGF) during ON trials. Furthermore, a comparison of the cytokine status between ON and OFF trials showed that basic immune status was stimulated slightly during ON trials under NCPIADC. Our overall findings indicate that the NCPDIAC device caused activation of NK activity and stimulated immune status, particularly only on NK activity, and therefore could be set in the home or office buildings.

## Linked entities

- **Proteins:** IL2 (interleukin 15)

## Full-text entities

- **Genes:** CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, MFSD11 (major facilitator superfamily domain containing 11) [NCBI Gene 79157] {aka ET}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, IFNA2 (interferon alpha 2) [NCBI Gene 3440] {aka IFN-alpha-2, IFN-alphaA, IFNA, IFNA2B, leIF A}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL7 (interleukin 7) [NCBI Gene 3574] {aka IL-7, IMD130}, CCL11 (C-C motif chemokine ligand 11) [NCBI Gene 6356] {aka SCYA11}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}
- **Diseases:** Cytotoxicity (MESH:D064420), lung, breast and other solitary tumors (MESH:D001943), NCPDIAC (MESH:D058747), mucous membrane irritation involving the eyes, nose and throat (MESH:D010390), urticaria (MESH:D014581), MCS (MESH:D018777), immunological disorders (MESH:D007154), SBS (MESH:D018877), irritability (MESH:D001523), chest tightness (MESH:D002637), skin dryness (MESH:D014987), skin ulcers (MESH:D012883), cancer (MESH:D009369), allergic problems (MESH:D004342), viral or bacterial infections (MESH:D014777), asthma (MESH:D001249), infectious diseases (MESH:D003141), influenza (MESH:D007251), infections (MESH:D007239), wheezing (MESH:D012135), fatigue (MESH:D005221), autoimmune disorders (MESH:D001327), ET (MESH:D016751), burn ulcers (MESH:D014456), headaches (MESH:D006261), metal allergy (MESH:D013651), inflammation (MESH:D007249)
- **Chemicals:** 8-OHdG (MESH:D000080242), G-SCSF (-), toluene (MESH:D014050), formaldehyde (MESH:D005557), charcoal (MESH:D002606), W (MESH:D014414), creatinine (MESH:D003404), xylene (MESH:D014992), VOC (MESH:D055549), ethyl acetate (MESH:C007650), metals (MESH:D008670), blood sugar (MESH:D001786),  (MESH:D016207)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** k562 — Xenopus laevis (African clawed frog), Transformed cell line (CVCL_C0YN)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4501842/full.md

---
Source: https://tomesphere.com/paper/PMC4501842